Point72 Asset Management
GOSS icon

Point72 Asset Management’s Gossamer Bio GOSS Stock Holding History

Point72 Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,250
Closed -$1.2M – 1618
2022
Q3 		$1.2M Buy
+1,250
New +$1.24M ﹤0.01% 1024

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Point72 Asset Management's GOSS Position: Q3 2023 in Review

Point72 Asset Management sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 436 shares — an estimated $41.9K sold.

Point72 Asset Management first reported a position in GOSS in Q2 2019 and held it in 4 quarters. The position peaked at $8.06M in Q2 2022. 94 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Point72 Asset Management reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Point72 Asset Management sold 436 Gossamer Bio shares in Q3 2023, an estimated $41.9K.
  • Point72 Asset Management first reported a position in Gossamer Bio in Q2 2019 and held it in 4 quarters.
  • Point72 Asset Management's Gossamer Bio position peaked at $8.06M in Q2 2022.
  • 94 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.